![Wolfgang Knirsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wolfgang Knirsch served as the Chairman-Management Board at Vita 34 AG from 2017 to 2022.
Prior to that, he was the Managing Director at stellacure GmbH and the Vice President-International Business at Biotest AG.
He holds a doctorate degree from RWTH Aachen University.
| Sociétés | Poste | Fin |
|---|---|---|
| FAMICORD AG | Directeur Général | 22/03/2022 |
| BIOTEST GMBH & CO. KGAA | Corporate Officer/Principal | - |
stellacure GmbH
 stellacure GmbH Medical/Nursing ServicesHealth Services Provides umbilical cord blood and stem cell banking services | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Biotest AG
 Biotest AG Pharmaceuticals: OtherHealth Technology Develops, manufactures and distributes therapy medicinal products | Health Technology |
RWTH Aachen University
 RWTH Aachen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
stellacure GmbH
stellacure GmbH Medical/Nursing ServicesHealth Services Provides umbilical cord blood and stem cell banking services | Health Services |
Vita 34 AG
 Vita 34 AG BiotechnologyHealth Technology Provides umbilical stem cell preservation and cord blood-banking services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
